Skip to main content
logo
Idorsia Ltd (SWX:IDIA)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
3.655
+0.040 (1.11%)
At close: Jan 30, 2026

Idorsia Revenue

Idorsia had revenue of 41.49M CHF in the quarter ending September 30, 2025, with 58.35% growth. This brings the company's revenue in the last twelve months to 232.51M, up 213.69% year-over-year. In the year 2024, Idorsia had annual revenue of 112.51M, down -26.17%.

Revenue (ttm)
232.51M
Revenue Growth
+213.69%
P/S Ratio
3.94
Revenue / Employee
357.71K
Employees
650
Market Cap
916.44M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024112.51M-39.88M-26.17%
Dec 31, 2023152.39M55.28M56.93%
Dec 31, 202297.10M61.75M174.70%
Dec 31, 202135.35M-36.41M-50.74%
Dec 31, 202071.76M47.94M201.26%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Basilea Pharmaceutica AG236.21M
Newron Pharmaceuticals55.93M
Santhera Pharmaceuticals Holding AG49.02M
BioVersys AG1.31M
Xlife Sciences AG839.38K
Molecular Partners AG681.00K
Addex Therapeutics158.54K
Revenue Rankings

Idorsia News

More News